TABLE 4.
Pharmacokinetic parameters of GS-441524 in mice, rats, monkeys, and dogs after single IV and PO administration.
| Species | IV* | PO** | |||||
|---|---|---|---|---|---|---|---|
| CLp (mL/min/kg) | Vdss (L/kg) | Cmax (ng/mL) | Tmax (h) | AUC0-∞ (ng·h/mL) | t1/2 (h) | F (%) | |
| Mouse*** | 26 | 2.4 | 582 | 1.5 | 2,540 | 3.9 | 39 |
| Rat | 25 ± 1.6 | 2.2 ± 0.3 | 193 ± 57 | 3.8 ± 2.4 | 2,170 ± 643 | 3.4 ± 0.2 | 33 ± 9.8 |
| Monkey | 9.5 ± 1.0 | 1.1 ± 0.04 | 59.4 ± 18.1 | 2.0 ± 0 | 734 ± 138 | 7.7 ± 1.4 | 8.3 ± 1.6 |
| Dog | 4.1 ± 0.70 | 0.92 ± 0.078 | 6,010 ± 1,400 | 0.28 ± 0.19 | 19,000 ± 5,200 | 4.1 ± 1.1 | 85 ± 17 |
*IV, dose: 5 mg/kg for mouse and rat; 2 mg/kg for dog and monkey.
**PO, dose: 10 mg/kg for mouse and rat; 5 mg/kg for dog and monkey.
***Mean concentrations at each time point were used in the pharmacokinetic parameter calculation.